TriSalus Life Sciences raises CFO base salary to $550K, grants performance-based stock options

TriSalus Life Sciences, Inc.

CFO David Patience's annual base salary increased from $450K to $550K, effective immediately.
Compensation Committee approved stock options for 249,899 shares at $5.11 per share.
Options vest upon company achieving ≥$75M revenue in any 12 consecutive months by Dec 31, 2027.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.